AMTD IDEA Group (NYSE: AMTD) faces NYSE price-compliance deadline
Rhea-AI Filing Summary
AMTD IDEA Group reported that it has received a letter from the New York Stock Exchange stating that its American depositary shares are below compliance standards because the average closing price was under US$1.00 per ADS over a consecutive 30 trading-day period.
The company has six months from receipt of the notice to regain compliance by achieving both a closing price and a 30 trading-day average of at least US$1.00 per ADS, or the NYSE will begin suspension and delisting procedures. AMTD IDEA plans to monitor market conditions and consider measures to cure the non-compliance, and it continues its share repurchase programs, having repurchased 4,417,036 ADSs as of August 7, 2026.
Positive
- None.
Negative
- NYSE non-compliance on US$1.00 ADS price with six‑month delisting risk.
Filing Explained
AMTD IDEA remains in the NYSE’s six-month cure period; it can regain compliance on the last trading day of any cure-period calendar month if both the closing ADS price and trailing 30-trading-day average are at least US$1, otherwise suspension and delisting procedures begin when the period expires.
Key Figures
Minimum ADS price requirement: US$1.00 per ADS
Compliance measurement period: 30 trading-day period
Cure Period length: six months
+1 more
4 metrics
Minimum ADS price requirement
US$1.00 per ADS
Minimum closing and 30 trading-day average price required by NYSE Section 802.01C
Compliance measurement period
30 trading-day period
Period over which average closing price must be at least US$1.00 per ADS
Cure Period length
six months
Time following receipt of NYSE notice to regain price compliance
ADSs repurchased
4,417,036 ADSs
Total repurchased under existing programs as of August 7, 2026
Key Terms
American depositary shares, Section 802.01C, Cure Period, delisting procedures, +1 more
5 terms
Section 802.01C regulatory
"Pursuant to Section 802.01C of the NYSE’s Listed Company Manual"
Cure Period regulatory
"The Company has six months (the “Cure Period”) following receipt of the notice"
A cure period is a set amount of time given to a borrower, counterparty, or contracting party to fix a missed payment, breach, or other problem before more serious consequences—like penalties, higher interest, or contract termination—kick in. For investors, it matters because it creates a short grace window that can prevent immediate losses and influence the timing and likelihood of recovery; think of it like a few extra days to pay a bill before a service is cut off.
delisting procedures regulatory
"the NYSE will commence suspension and delisting procedures"
Delisting procedures are the formal steps an exchange and a company follow to remove a company's shares from a public trading venue. Like a store pulling an item off the shelf, the process can be triggered by failure to meet financial or reporting rules, bankruptcy, or a voluntary decision, and it matters to investors because it can sharply reduce the ability to buy or sell shares, change where the stock trades, and often affects the share’s value and recoverability.
forward-looking statements regulatory
"This press release contains statements that may constitute “forward-looking” statements"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
Why did AMTD (AMTD IDEA Group) receive a NYSE non-compliance letter?
AMTD IDEA received a NYSE letter because the average closing price of its American depositary shares was below US$1.00 over a consecutive 30 trading-day period, triggering the exchange’s minimum share price compliance rules.
What minimum ADS price must AMTD (AMTD IDEA Group) meet on the NYSE?
To regain compliance, AMTD IDEA must achieve at least US$1.00 per ADS as both the closing share price and the average closing price over a 30 trading-day period, measured on the last trading day of a calendar month within the cure window.
How long does AMTD (AMTD IDEA Group) have to regain NYSE compliance?
AMTD IDEA has a six-month Cure Period from receipt of the NYSE notice to restore compliance by meeting the US$1.00 per ADS closing and 30 trading-day average price thresholds, or it faces the start of suspension and delisting procedures.
What happens if AMTD (AMTD IDEA Group) fails to cure the NYSE deficiency?
If AMTD IDEA does not meet both US$1.00 per ADS closing and 30 trading-day average price requirements by the end of the six-month Cure Period, the NYSE will commence suspension and delisting procedures for the company’s ADSs.
How many ADSs has AMTD (AMTD IDEA Group) repurchased so far?
As of August 7, 2026, AMTD IDEA has repurchased 4,417,036 ADSs under its existing share repurchase programs, which the company plans to continue while addressing the NYSE trading price non-compliance.
What actions does AMTD (AMTD IDEA Group) plan regarding its NYSE non-compliance?
AMTD IDEA states it intends to monitor market conditions for its listed securities and consider various measures to cure the trading-price-related non-compliance and avoid potential delisting, while continuing its previously announced share repurchase programs.